QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes
19 December 2007 - 6:57AM
PR Newswire (US)
NEW YORK, Dec. 18 /PRNewswire/ -- QED International Associates
Inc., administrator for the HealthShares(TM) Exchange-Traded Funds,
a series of 20 underlying fund portfolios, today announced the
quarterly rebalancing of the Indexes. The following securities will
be added and deleted in the Indexes effective before the opening of
trading on NYSE Arca December 24, 2007. Autoimmune-Inflammation
Index (HHA) Drop Immunomedics, Inc. Nasdaq: IMMU Add Synta
Pharmaceuticals, Inc. Nasdaq: SNTA Cardiology Devices Index (HHE)
Drop NMT Medical Inc. Nasdaq: NMTI Add Boston Scientific, Inc.
NYSE: BSX Dermatology and Wound Index (HRW) Drop Watson
Pharmaceuticals Inc. NYSE: WPI Add Obagi Medical Products, Inc.
Nasdaq: OMPI GI/Gender Index (HHU) Drop Neurocrine Biosciences,
Inc. Nasdaq: NBIX Add Perrigo Company, Inc. Nasdaq: PRGO
Metabolic-Endocrine Disorders Index (HHM) Drop Metabais
Therapeutics Inc. Nasdaq: MBRX Add Hospira, Inc. NYSE: HSP
Opthalmology Index (HHZ) Drop Oxigene Inc. Nasdaq: OXGN Staar
Surgical Co. Nasdaq: STAA Watson Pharmaceuticals Inc. NYSE: WPI Add
Hi-Tech Pharmacal Co. Inc. Nasdaq: HITK ISIS Pharmaceuticals Inc.
Nasdaq: ISIS Opko Health, Inc. AMEX: OPK The rebalanced Indexes,
including the rebalanced Index Shares, are based on the closing
prices as of December 17, 2007. In accordance with the Exemptive
Order, a complete list of the constituents reflecting the
rebalancing will be posted at
http://www.healthsharesinc.com/content/view/53/274/. About
HealthShares(TM) XShares Advisors LLC, a financial services company
based in New York, is the creator of the HealthShares(TM) family of
Exchange Traded Funds (ETFs). HealthShares(TM) ETFs are organized
into therapeutic 'Verticals' and represent specific areas of the
healthcare, life science and biotechnology industries. Each
Vertical addresses a distinct sub-segment of healthcare, such as
the diagnosis and treatment of specific therapeutic areas (e.g.
cardiology, cancer, infectious disease, etc.) and the development
of medical devices (e.g. orthopedic repair, cardio devices, etc.).
Each ETF tracks an index of 22-25 stocks and offers institutional
and individual investors a more precise financial instrument that
leverages the potential of healthcare investing while mitigating
the risks of single stock picking. For more information, visit the
company's website at: http://www.healthsharesinc.com/. About
XShares XShares Advisors LLC, a subsidiary of XShares Group LLC, is
a registered investment advisor that provides investment advisory
services to Exchange Traded Funds. XShares also partners with major
institutions and index providers seeking to bring innovative
Exchange Traded Funds to market using its administrative platform.
In addition, XShares creates and licenses distinctive intellectual
property for its ETFs, developing products that allow for
innovative trading strategies and alternative investments for the
financial community. For more information, visit the company's
website at http://www.xsharesadvisors.com/. About QED International
Associates QED International, based in New York, is a leading
financial industry consulting firm specializing in quantitative
modeling and the design, development and maintenance of indexes and
Exchange Traded Funds. For more information, visit the company's
website at http://www.qedinternational.com/ DATASOURCE: QED
International Associates Inc. CONTACT: Ed Matluck, CEO, , or
Michael Carty, both of QED International, +1-212-953-4058; John T.
McInerney of Makovsky + Company for XShares Advisors LLC,
+1-212-508-9628, Web site: http://www.xsharesadvisors.com/
http://www.healthsharesinc.com/
http://www.healthsharesinc.com/content/view/53/274
Copyright